News
Here, we share stories about our research, innovations in biotechnology, partnerships, and the people behind our mission to support better health from within. Stay informed, stay inspired, and explore how Bioxyne continues to advance science for a healthier tomorrow.
ABC News: Inside the legal MDMA and psilocybin magic mushroom trade
For the first time, the ABC can take you behind the scenes of its production line, inside the vaults, and...
Bioxyne Secures A$50 Million Medicinal Cannabis Supply Agreement in German Market
Bioxyne (ASX:BXN) has announced a $50 million exclusive medicinal cannabis supply agreement with German pharmaceutical company ADREXpharma. This two-year contract, facilitated through...
Bioxyne lands $50 million two year German supply deal with ADREX
Bioxyne (ASX:BXN) has secured a two-year supply agreement worth up to $50 million with German pharmaceutical company ADREXpharma GmbH, a...
Bioxyne Signs $50m Exclusive German Supply Deal with ADREX
Bioxyne lands $50m exclusive German supply deal with ADREXpharma, securing $25m minimum in first year, boosting Europe revenue visibility and...
Bioxyne lands first Costa Rica flower supply deal
Bioxyne subsidiary Breathe Life Sciences (BLS) has signed its first medicinal cannabis flower supply agreement in Costa Rica. The deal...
BREATHE LIFE SCIENCES | A BREATH OF FRESH AIR
Bioxyne partners with Aurora Cannabis
Australian Bioxyne Limited has signed a manufacturing agreement with global medical cannabis company Aurora Cannabis Inc., marking a significant step...
Manufacturing deal signed between Bioxyne and Aurora Cannabis for medicinal products
Bioxyne Limited has announced a new manufacturing agreement with Aurora Cannabis Inc., placing manufacturing at the center of a partnership...